HJRES 54
110th Congress
House
Health
Administrative procedure
Blood
Cancer
Congress
Congressional veto
Department of Health and Human Services
Government Operations and Politics
Law
Medicare
Social Welfare
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Introduced: September 27, 2007
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2007
Referred to the Subcommittee on Health.
Oct 3, 2007
Referred to the Subcommittee on Health.
Sep 27, 2007
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 27, 2007
Introduced in House
Plain-English summary
Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Declares that such rule shall have no force or effect.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4